Celebrating Hemp Week: Be an Advocate!
By Michelle Bodian
Jun 10, 2020
As we reflect on hemp industry progress during Hemp Week, let's also take action to move this industry forward with the following vital initiatives...
Insights
Public Comment on the DEA Proposed Rules for the Cultivation of Marijuana for Research Purposes
Jun 1, 2020
The DEA accepted public comments on rules to enhance the cultivation of “marihuana” for research purposes in the US. View the comment from Vicente Sederberg LLP.
Epidiolex Was Removed from the CSA. Now What?
By Corey Cox
May 28, 2020
The CBD-based medicine, Epidiolex, was descheduled by the DEA and is no longer a controlled substance. What are the implications of this change and what, if anything, does it mean for CBD products in general?
Coronavirus and Cannabis: Michigan Regulatory Updates
By Sahar Ayinehsazian and Kelsey Middleton
May 28, 2020
Vicente Sederberg is monitoring the potential impact of the coronavirus (COVID-19) on cannabis businesses, service providers, and consumers in Michigan.
10 Tips for U.S. Cannabis Businesses Facing an Economic Downturn
By Phil Silverman
May 20, 2020
The U.S. is facing its gravest economic crisis since the Great Depression due to the coronavirus pandemic. These 10 concepts are not necessarily unique to cannabis businesses, but in an industry that’s already subject to greater federal, state and local scrutiny, they can serve as a guide for those seeking to relieve their financial stress.
WELCOME TO VICENTE INSIGHTS!
Commentary and analysis on cannabis, hemp, psychedelics, and other emerging therapies from the attorneys and policy specialists at the nation’s leading cannabis law firm.